KBC Group NV lessened its stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 43.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 104,988 shares of the real estate investment trust’s stock after selling 82,081 shares during the quarter. KBC Group NV’s holdings in Healthpeak Properties were worth $2,123,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of DOC. Mizuho Bank Ltd. bought a new stake in shares of Healthpeak Properties in the fourth quarter worth about $28,000. Harvest Fund Management Co. Ltd bought a new position in shares of Healthpeak Properties during the fourth quarter worth about $30,000. Future Financial Wealth Managment LLC bought a new position in shares of Healthpeak Properties during the first quarter worth about $30,000. S.A. Mason LLC grew its holdings in shares of Healthpeak Properties by 160.9% during the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 925 shares in the last quarter. Finally, Covestor Ltd grew its holdings in shares of Healthpeak Properties by 173.8% during the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock worth $37,000 after buying an additional 1,152 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors.
Insider Transactions at Healthpeak Properties
In related news, Director Tommy G. Thompson acquired 5,777 shares of the stock in a transaction on Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the purchase, the director directly owned 144,290 shares in the company, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Scott M. Brinker acquired 11,337 shares of the stock in a transaction on Monday, April 28th. The shares were bought at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the purchase, the chief executive officer owned 201,863 shares in the company, valued at approximately $3,568,937.84. This trade represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 29,764 shares of company stock worth $521,909. Company insiders own 0.23% of the company’s stock.
Healthpeak Properties Stock Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.46. The company had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.45 earnings per share. On average, equities research analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The company also recently announced a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were paid a dividend of $0.1017 per share. The ex-dividend date was Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 305.00%.
Analyst Ratings Changes
DOC has been the subject of a number of research reports. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, June 29th. Wedbush decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Evercore ISI decreased their price objective on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Wells Fargo & Company decreased their price objective on Healthpeak Properties from $22.00 to $20.00 and set an “equal weight” rating for the company in a report on Monday, June 2nd. Finally, Argus reiterated a “buy” rating and set a $25.00 price objective on shares of Healthpeak Properties in a report on Tuesday, April 29th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $23.27.
Read Our Latest Stock Analysis on DOC
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- How to Most Effectively Use the MarketBeat Earnings Screener
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- What Makes a Stock a Good Dividend Stock?
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.